Engaging patients in medicines regulation: a tale of two agencies
The European Medicines Agency and the US Food and Drug Administration have committed to engaging patients in their regulatory processes to promote patient-focused medicinal product development, as well as improve transparency and trust in the regulatory system. Here, we highlight exchanges of experi...
Gespeichert in:
| Veröffentlicht in: | Nature reviews. Drug discovery 2019-11, Vol.18 (12), p.885-886 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 886 |
|---|---|
| container_issue | 12 |
| container_start_page | 885 |
| container_title | Nature reviews. Drug discovery |
| container_volume | 18 |
| creator | Mavris, Maria Furia Helms, Andrea Bere, Nathalie |
| description | The European Medicines Agency and the US Food and Drug Administration have committed to engaging patients in their regulatory processes to promote patient-focused medicinal product development, as well as improve transparency and trust in the regulatory system. Here, we highlight exchanges of experience between the agencies and some impacts on patient engagement.
The European Medicines Agency and the US Food and Drug Administration have committed to engaging patients in their regulatory processes to promote patient-focused medicinal product development, as well as improve transparency and trust in the regulatory system. Here, we highlight exchanges of experience between the agencies and some impacts on patient engagement. |
| doi_str_mv | 10.1038/d41573-019-00164-y |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2320388396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A607596995</galeid><sourcerecordid>A607596995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-952094876f9c168fe2510e3a5cad8c7e656ea5c94e332ceee961490cd4c6ba3c3</originalsourceid><addsrcrecordid>eNp9kUlLLDEUhYMozn_AhQTcuCnNVEnFXSNOILjRdYipW0WkOmmTKqT__Uu_dkARySLTd07uzUHoiJIzSnhz3gpaK14RqitCqBTVcgPtUqFERVUjNj_XSu6gvZxfVhBVbBvt8AKQRrBdNLsKve196PHCjh7CmLEPeA6tdz5Axgn6aSg3MVxgi0c7AI4dHt8itj0E5yEfoK3ODhkO3-d99HR99Xh5W90_3Nxdzu4rJxQZK10zokWjZKcdlU0HrKYEuK2dbRunQNYSykYL4Jw5ANCSCk1cK5x8ttzxfXS69l2k-DpBHs3cZwfDYAPEKRvGWfmUhmtZ0JMf6EucUijVGU45l0QxUv9FMU5LrbSR6ovqS-_Ghy6OybrV02ZWjGottV55nf1CldHC3LsYoPPl_JuArQUuxZwTdGaR_NympaHErNI163RNSdf8T9csi-j4veLpuUT0KfmIswB8DeRyFXpIXy39YfsPQ_OsOQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2319481867</pqid></control><display><type>article</type><title>Engaging patients in medicines regulation: a tale of two agencies</title><source>MEDLINE</source><source>Nature</source><source>Springer Nature - Complete Springer Journals</source><creator>Mavris, Maria ; Furia Helms, Andrea ; Bere, Nathalie</creator><creatorcontrib>Mavris, Maria ; Furia Helms, Andrea ; Bere, Nathalie</creatorcontrib><description>The European Medicines Agency and the US Food and Drug Administration have committed to engaging patients in their regulatory processes to promote patient-focused medicinal product development, as well as improve transparency and trust in the regulatory system. Here, we highlight exchanges of experience between the agencies and some impacts on patient engagement.
The European Medicines Agency and the US Food and Drug Administration have committed to engaging patients in their regulatory processes to promote patient-focused medicinal product development, as well as improve transparency and trust in the regulatory system. Here, we highlight exchanges of experience between the agencies and some impacts on patient engagement.</description><identifier>ISSN: 1474-1776</identifier><identifier>EISSN: 1474-1784</identifier><identifier>DOI: 10.1038/d41573-019-00164-y</identifier><identifier>PMID: 31780842</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Caregivers ; Clinical trials ; Collaboration ; Comment ; Committees ; Consumers ; Decision making ; Drug Approval - legislation & jurisprudence ; Drugs ; European Union ; Government Agencies - legislation & jurisprudence ; Humans ; Laws, regulations and rules ; Medicine ; Patient Participation ; Patients ; Pharmacovigilance ; Prescription Drugs - standards ; Product development ; Public hearings ; Regulatory approval ; United States ; United States Food and Drug Administration</subject><ispartof>Nature reviews. Drug discovery, 2019-11, Vol.18 (12), p.885-886</ispartof><rights>Springer Nature Limited 2019</rights><rights>COPYRIGHT 2019 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Nov 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-952094876f9c168fe2510e3a5cad8c7e656ea5c94e332ceee961490cd4c6ba3c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/d41573-019-00164-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/d41573-019-00164-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31780842$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mavris, Maria</creatorcontrib><creatorcontrib>Furia Helms, Andrea</creatorcontrib><creatorcontrib>Bere, Nathalie</creatorcontrib><title>Engaging patients in medicines regulation: a tale of two agencies</title><title>Nature reviews. Drug discovery</title><addtitle>Nat Rev Drug Discov</addtitle><addtitle>Nat Rev Drug Discov</addtitle><description>The European Medicines Agency and the US Food and Drug Administration have committed to engaging patients in their regulatory processes to promote patient-focused medicinal product development, as well as improve transparency and trust in the regulatory system. Here, we highlight exchanges of experience between the agencies and some impacts on patient engagement.
The European Medicines Agency and the US Food and Drug Administration have committed to engaging patients in their regulatory processes to promote patient-focused medicinal product development, as well as improve transparency and trust in the regulatory system. Here, we highlight exchanges of experience between the agencies and some impacts on patient engagement.</description><subject>Caregivers</subject><subject>Clinical trials</subject><subject>Collaboration</subject><subject>Comment</subject><subject>Committees</subject><subject>Consumers</subject><subject>Decision making</subject><subject>Drug Approval - legislation & jurisprudence</subject><subject>Drugs</subject><subject>European Union</subject><subject>Government Agencies - legislation & jurisprudence</subject><subject>Humans</subject><subject>Laws, regulations and rules</subject><subject>Medicine</subject><subject>Patient Participation</subject><subject>Patients</subject><subject>Pharmacovigilance</subject><subject>Prescription Drugs - standards</subject><subject>Product development</subject><subject>Public hearings</subject><subject>Regulatory approval</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>1474-1776</issn><issn>1474-1784</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kUlLLDEUhYMozn_AhQTcuCnNVEnFXSNOILjRdYipW0WkOmmTKqT__Uu_dkARySLTd07uzUHoiJIzSnhz3gpaK14RqitCqBTVcgPtUqFERVUjNj_XSu6gvZxfVhBVbBvt8AKQRrBdNLsKve196PHCjh7CmLEPeA6tdz5Axgn6aSg3MVxgi0c7AI4dHt8itj0E5yEfoK3ODhkO3-d99HR99Xh5W90_3Nxdzu4rJxQZK10zokWjZKcdlU0HrKYEuK2dbRunQNYSykYL4Jw5ANCSCk1cK5x8ttzxfXS69l2k-DpBHs3cZwfDYAPEKRvGWfmUhmtZ0JMf6EucUijVGU45l0QxUv9FMU5LrbSR6ovqS-_Ghy6OybrV02ZWjGottV55nf1CldHC3LsYoPPl_JuArQUuxZwTdGaR_NympaHErNI163RNSdf8T9csi-j4veLpuUT0KfmIswB8DeRyFXpIXy39YfsPQ_OsOQ</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Mavris, Maria</creator><creator>Furia Helms, Andrea</creator><creator>Bere, Nathalie</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20191101</creationdate><title>Engaging patients in medicines regulation: a tale of two agencies</title><author>Mavris, Maria ; Furia Helms, Andrea ; Bere, Nathalie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-952094876f9c168fe2510e3a5cad8c7e656ea5c94e332ceee961490cd4c6ba3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Caregivers</topic><topic>Clinical trials</topic><topic>Collaboration</topic><topic>Comment</topic><topic>Committees</topic><topic>Consumers</topic><topic>Decision making</topic><topic>Drug Approval - legislation & jurisprudence</topic><topic>Drugs</topic><topic>European Union</topic><topic>Government Agencies - legislation & jurisprudence</topic><topic>Humans</topic><topic>Laws, regulations and rules</topic><topic>Medicine</topic><topic>Patient Participation</topic><topic>Patients</topic><topic>Pharmacovigilance</topic><topic>Prescription Drugs - standards</topic><topic>Product development</topic><topic>Public hearings</topic><topic>Regulatory approval</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mavris, Maria</creatorcontrib><creatorcontrib>Furia Helms, Andrea</creatorcontrib><creatorcontrib>Bere, Nathalie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Drug discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mavris, Maria</au><au>Furia Helms, Andrea</au><au>Bere, Nathalie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engaging patients in medicines regulation: a tale of two agencies</atitle><jtitle>Nature reviews. Drug discovery</jtitle><stitle>Nat Rev Drug Discov</stitle><addtitle>Nat Rev Drug Discov</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>18</volume><issue>12</issue><spage>885</spage><epage>886</epage><pages>885-886</pages><issn>1474-1776</issn><eissn>1474-1784</eissn><abstract>The European Medicines Agency and the US Food and Drug Administration have committed to engaging patients in their regulatory processes to promote patient-focused medicinal product development, as well as improve transparency and trust in the regulatory system. Here, we highlight exchanges of experience between the agencies and some impacts on patient engagement.
The European Medicines Agency and the US Food and Drug Administration have committed to engaging patients in their regulatory processes to promote patient-focused medicinal product development, as well as improve transparency and trust in the regulatory system. Here, we highlight exchanges of experience between the agencies and some impacts on patient engagement.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>31780842</pmid><doi>10.1038/d41573-019-00164-y</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1474-1776 |
| ispartof | Nature reviews. Drug discovery, 2019-11, Vol.18 (12), p.885-886 |
| issn | 1474-1776 1474-1784 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2320388396 |
| source | MEDLINE; Nature; Springer Nature - Complete Springer Journals |
| subjects | Caregivers Clinical trials Collaboration Comment Committees Consumers Decision making Drug Approval - legislation & jurisprudence Drugs European Union Government Agencies - legislation & jurisprudence Humans Laws, regulations and rules Medicine Patient Participation Patients Pharmacovigilance Prescription Drugs - standards Product development Public hearings Regulatory approval United States United States Food and Drug Administration |
| title | Engaging patients in medicines regulation: a tale of two agencies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A24%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engaging%20patients%20in%20medicines%20regulation:%20a%20tale%20of%20two%20agencies&rft.jtitle=Nature%20reviews.%20Drug%20discovery&rft.au=Mavris,%20Maria&rft.date=2019-11-01&rft.volume=18&rft.issue=12&rft.spage=885&rft.epage=886&rft.pages=885-886&rft.issn=1474-1776&rft.eissn=1474-1784&rft_id=info:doi/10.1038/d41573-019-00164-y&rft_dat=%3Cgale_proqu%3EA607596995%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2319481867&rft_id=info:pmid/31780842&rft_galeid=A607596995&rfr_iscdi=true |